Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.03.30
ag真人平台官方：独立董事提名人声明（黄鹏）
2023.03.30
ag真人平台官方：独立董事候选人声明（黄鹏）
2023.03.30
ag真人平台官方：关于2023年度向银行申请授信额度暨提供担保的公告
2023.03.30
ag真人平台官方：董事会决议公告
2023.03.30
ag真人平台官方：关于续聘会计师事务所的公告
2023.03.30
ag真人平台官方：独立董事候选人关于参加最近一次独立董事培训的书面承诺
2023.03.30
ag真人平台官方：公司章程（2023年3月）
2023.03.30
ag真人平台官方：独立董事年度述职报告
2023.03.30
ag真人平台官方：2022年年度报告摘要
2023.03.30
ag真人平台官方：关于使用自有资金购买理财产品及进行现金管理的公告
第一页
上一页
7
8
9
10
11
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
